Jones David Scott

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$1.76M

Insider Activity of Jones David Scott

According to the SEC Form 4 filings, Jones David Scott, being in a position of

  1. SVP & Chief Commercial Officer at EyePoint Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 73192 shares for $1.76M,
    over all time since 2024-01-22, has bought 0 shares, and sold 73192 shares for $1.76M.

The largest sale of all time was on 2024-01-22 and amounted to 34166 shares of EyePoint Pharmaceuticals, Inc. for $772,691.

Biography of Jones David Scott

No biography is available at this moment.

2024-02-02SaleEyePoint Pharmaceuticals, Inc.
EYPT
SVP & Chief Commercial Officer
209
0.0007%
$28.49$5,954-62.54%
2024-01-26SaleEyePoint Pharmaceuticals, Inc.
EYPT
SVP & Chief Commercial Officer
26,017
0.0509%
$25.38$660,370-58.79%
2024-01-25SaleEyePoint Pharmaceuticals, Inc.
EYPT
SVP & Chief Commercial Officer
600
0.0012%
$25.00$15,000-55.73%
2024-01-24SaleEyePoint Pharmaceuticals, Inc.
EYPT
SVP & Chief Commercial Officer
11,300
0.0335%
$25.01$282,621-53.72%
2024-01-23SaleEyePoint Pharmaceuticals, Inc.
EYPT
SVP & Chief Commercial Officer
900
0.0026%
$25.00$22,500-55.35%
2024-01-22SaleEyePoint Pharmaceuticals, Inc.
EYPT
SVP & Chief Commercial Officer
34,166
0.0914%
$22.62$772,691-53.61%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.